SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Profiteer who wrote (50)	6/5/1998 12:57:00 PM
From: Gwolf	Read Replies (1) of 5402

Chirodoc, That wording is very standard. One thing the SEC wants companies to do is give full disclosure and they require that it be presented with the most negative possible outcome so that investors will have their eyes open when they invest. If you look at the same material for any Biotech company they read the same. Most of the high flying Biotechs do not make a dime, it is the anticipation that they will finally have a major product take off that keeps the stocks going. The contract that we are waiting for will provide them with the funding they need to get the animal testing started. If the animal testing is successful then they won't need to worry about funding for the human trials because they will have major drug companies ready to throw money at them for the next stage. Remeber one thing their original product was tested on humans and received a patent. This is the next generation , so if the first one worked on humans you can make an assumption that the newer version will work even better and certainly should work on animals. Gwolf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next